|
|
Volumn 59, Issue 1, 2014, Pages 13-15
|
|
Expanding access to hepatitis C virus care: A call to deconstruct individualized therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
BOCEPREVIR;
CYCLOPHILIN INHIBITOR;
HEPACIVIRIN INHIBITOR;
INTERFERON;
NONSTRUCTURAL PROTEIN 5A INHIBITOR;
NONSTRUCTURAL PROTEIN 5B INHIBITOR;
PEGINTERFERON;
PROTEINASE INHIBITOR;
RIBAVIRIN;
TELAPREVIR;
UNCLASSIFIED DRUG;
EDITORIAL;
GENETIC POLYMORPHISM;
GENOTYPE;
HEALTH CARE ACCESS;
HEALTH CARE QUALITY;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
LABORATORY TEST;
MONOTHERAPY;
PATIENT CARE;
PERSONALIZED MEDICINE;
PRIORITY JOURNAL;
TREATMENT DURATION;
TREATMENT RESPONSE;
ECONOMICS;
HEALTH CARE DELIVERY;
ANTIVIRAL AGENTS;
HEALTH SERVICES ACCESSIBILITY;
HEPATITIS C;
HUMANS;
INDIVIDUALIZED MEDICINE;
|
|
EID: 84894535399
PISSN: 02709139
EISSN: 15273350
Source Type: Journal
DOI: 10.1002/hep.26590 Document Type: Editorial |
|
Times cited : (12)
|
|
References (6)
|
